Surrozen, Inc./DE Increase Decrease In Operating Lease Liability
Surrozen, Inc./DE (SRZN) reported Increase Decrease In Operating Lease Liability of -$323.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- Surrozen, Inc./DE increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$462.00K.
- Surrozen, Inc./DE increase decrease in operating lease liability for the quarter ending 2026-03-31 was $139.00K.
- Surrozen, Inc./DE increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$443.00K.
- Surrozen, Inc./DE increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$432.00K.
- Surrozen, Inc./DE increase decrease in operating lease liability for fiscal 2025 was -$1.83M.
- Surrozen, Inc./DE increase decrease in operating lease liability for fiscal 2024 was -$2.34M.
- Surrozen, Inc./DE increase decrease in operating lease liability for fiscal 2023 was -$2.22M.
- Surrozen, Inc./DE increase decrease in operating lease liability for fiscal 2022 was -$2.19M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$323.00K 10-Q · filed 2026-08-06 | -$766.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $139.00K 10-Q · filed 2026-05-06 | -$304.00K derived: sum of 2 quarters · filed 2026-05-06 | -$736.00K derived: sum of 3 quarters · filed 2026-05-06 | -$1.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$875.00K derived: sum of 2 quarters · filed 2026-03-23 | -$1.33M derived: sum of 3 quarters · filed 2026-08-06 | -$1.83M 10-K · filed 2026-03-23 |
| 2025-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$886.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.39M 10-Q · filed 2025-11-07 | -$1.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$454.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$955.00K 10-Q · filed 2026-08-06 | -$1.45M derived: sum of 3 quarters · filed 2026-08-06 | -$2.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$501.00K 10-Q · filed 2026-05-06 | -$993.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.63M derived: sum of 3 quarters · filed 2026-05-06 | -$2.25M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$1.13M derived: sum of 2 quarters · filed 2026-03-23 | -$1.75M derived: sum of 3 quarters · filed 2026-03-23 | -$2.34M 10-K · filed 2026-03-23 |
| 2024-09-30 | -$639.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.26M derived: sum of 2 quarters · filed 2025-11-07 | -$1.85M 10-Q · filed 2025-11-07 | -$2.43M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$620.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.21M 10-Q · filed 2025-08-08 | -$1.79M derived: sum of 3 quarters · filed 2025-08-08 | -$2.36M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$593.00K 10-Q · filed 2025-05-09 | -$1.17M derived: sum of 2 quarters · filed 2025-05-09 | -$1.74M derived: sum of 3 quarters · filed 2025-05-09 | -$2.29M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$580.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.15M derived: sum of 2 quarters · filed 2025-03-31 | -$1.70M derived: sum of 3 quarters · filed 2025-03-31 | -$2.22M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$569.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$1.12M derived: sum of 2 quarters · filed 2024-11-06 | -$1.64M 10-Q · filed 2024-11-06 | -$2.16M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$549.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$1.07M 10-Q · filed 2024-08-12 | -$1.59M derived: sum of 3 quarters · filed 2024-08-12 | -$2.09M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$525.00K 10-Q · filed 2024-05-08 | -$1.04M derived: sum of 2 quarters · filed 2024-05-08 | -$1.54M derived: sum of 3 quarters · filed 2024-05-08 | -$2.14M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | -$1.02M derived: sum of 2 quarters · filed 2024-04-10 | -$1.61M derived: sum of 3 quarters · filed 2024-04-10 | -$2.19M 10-K · filed 2024-04-10 |
| 2022-09-30 | -$503.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.10M derived: sum of 2 quarters · filed 2023-11-08 | -$1.68M 10-Q · filed 2023-11-08 | -$2.15M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$598.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.17M 10-Q · filed 2023-08-09 | -$1.65M derived: sum of 3 quarters · filed 2023-08-09 | -$2.20M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$576.00K 10-Q · filed 2023-05-10 | -$1.05M derived: sum of 2 quarters · filed 2023-05-10 | -$1.60M derived: sum of 3 quarters · filed 2023-05-10 | -$2.13M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.03M derived: sum of 2 quarters · filed 2023-03-31 | -$1.55M derived: sum of 3 quarters · filed 2023-03-31 | -$2.06M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.08M derived: sum of 2 quarters · filed 2022-11-14 | -$1.58M 10-Q · filed 2022-11-14 | -$2.08M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.03M 10-Q · filed 2022-08-11 | -$1.53M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$507.00K 10-Q · filed 2022-05-11 | -$1.00M derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$1.67M 10-K · filed 2022-03-28 | ||
| 2020-09-30 | -$1.17M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |